Updated Jan 02, 2024, 3:24 pm EST / Original Jan 02, 2024, 8:25 am EST
Reprints
Shares of Covid-19 vaccine maker Moderna were on track for their best single-day performance in more than a year, after an analyst at Oppenheimer issued a rare upgrade of the stock.
Continue reading this article with a Barron’s subscription.
View Options